Life Briefing: STAT+: A biotech turns to Apple Watch to study its Parkinson’s drug Strategic angle: In this edition of STAT Health Tech: How Apple Watch is being used in a clinical trial for a Parkinson's drug, and more editorial-staff Mar 19
Life Two doctors on the challenges of medicine today In today's Morning Rounds newsletter, a Texas couple getting rich off out-of-network medical bills, two doctors on the challenges of medicine today, and more. editorial-staff Mar 19
Life Briefing: Eli Lilly’s ‘triple-G’ drug leads to significant blood sugar, weight reductions in diabetes trial Strategic angle: Diabetes patients taking an investigational drug from Eli Lilly saw significant reductions in their blood sugar and weight in a late-stage study. editorial-staff Mar 19
Life Briefing: STAT+: Six drugmakers, six months: Charting the FDA’s course in the post-Prasad era Strategic angle: Will the FDA’s regulatory policies, particularly for rare-disease drugs, shift in the wake of Vinay Prasad’s imminent departure? editorial-staff Mar 19
Life Cost Concerns and Coverage Changes: A Follow-Up Survey of ACA Marketplace Enrollees This KFF survey examines the cost concerns and coverage changes experienced by ACA Marketplace enrollees in 2025 following the expiration of enhanced benefits. editorial-staff Mar 19
Life Briefing: HHS Watchdog Critiques Nursing Homes for Antipsychotic Drug Misuse Strategic angle: Nursing homes misuse antipsychotic drugs for dementia patients, disguising the practice as schizophrenia treatment, a watchdog finds. editorial-staff Mar 19
Life Briefing: FDA’s top infectious disease regulator to depart agency Strategic angle: Adam Sherwat, the director of the Office of Infectious Diseases in the FDA’s Center for Drug Evaluation and Research, is leaving the agency. editorial-staff Mar 18
Life Briefing: More than 150,000 uncounted Covid-19 deaths occurred early in the pandemic, a study finds Strategic angle: The Covid-19 pandemic's early death toll was much higher than the official U.S. count, according to a new study that spotlights dramatic disparities in the uncounted deaths. editorial-staff Mar 18
Life Briefing: Maryland Legislator Proposes Bill for Pharma Transparency in Disease Awareness Campaigns Strategic angle: A new bill aims to mandate drugmakers and patient groups to reveal their connections to disease awareness initiatives. editorial-staff Mar 18
Life Briefing: Clearing tumors in mice, Azalea Therapeutics advances dream of in vivo CAR-T therapy Strategic angle: A mouse study shows CAR-T cells can be engineered in vivo with precise gene editing, a potential breakthrough that could cut costs and expand access. editorial-staff Mar 18
Life Briefing: STAT+: How ARPA-H is developing FDA-authorized AI agents, tested in clinical trials Strategic angle: STAT's AI Prognosis takes a closer look at how the U.S. moonshot agency for health research is developing AI agents for deployment in hospitals. editorial-staff Mar 18
Life Briefing: A Huntington’s researcher on the UniQure-FDA fray Strategic angle: A Huntington's researcher treads lightly into the UniQure-FDA fray, J&J wins approval for a first-of-its kind psoriasis pill, and more in today's Readout newsletter. editorial-staff Mar 18
Life Briefing: Premature menopause is linked to 40% increase in heart disease risk Strategic angle: JAMA Cardiology study highlights the increased heart disease risk associated with premature menopause, particularly among Black women. editorial-staff Mar 18
Life Briefing: As Trump administration cracks down on health care fraud, people with disabilities feel singled out Strategic angle: As the Trump administration goes after fraud in health care, advocates say the disability community feels singled out. editorial-staff Mar 18
Life Briefing: STAT+: Pharmalittle: We’re reading about TrumpRx prices, a J&J psoriasis pill, and much more Strategic angle: U.S. health officials claim TrumpRx offers Americans the world’s lowest prices on prescription drugs, but a new analysis found that is not true. editorial-staff Mar 18
Life Briefing: FDA and NIH announce more initiatives to reduce animal testing in drug development Strategic angle: The HHS has made reducing animal testing a priority over the past year. editorial-staff Mar 18
Life Briefing: Quiz – How Well Do You Understand Your Health Insurance – Frameless Strategic angle: Test your knowledge on health insurance with this 10-question quiz to make informed decisions about your coverage. editorial-staff Mar 18
Life Briefing: J&J Wins Approval for First-of-its-Kind Psoriasis Pill Strategic angle: Johnson & Johnson's new daily psoriasis pill offers benefits comparable to injectable treatments, potentially disrupting a multibillion-dollar market. editorial-staff Mar 18
Life Briefing: Drug smoking can lead to severe burns, complicating harm reduction efforts Strategic angle: A new study reveals that opioid smokers are four times more likely to suffer severe burns compared to those who inject drugs. editorial-staff Mar 18
Life Briefing: Opinion: Exposed and invisible in an ER hallway bed Strategic angle: Hallway beds cut into the bones that sustain emergency medicine, shaving away layers of moral tenets and high standards. editorial-staff Mar 18